Strome Mark E's Form 4 filing
Zivo Bioscience, Inc. (ZIVO) · filed Dec 31, 2024
- Accession no.
- 0001213900-24-113655
- Filed
- Dec 31, 2024, 6:47 AM ET
- Trade date
- Dec 26, 2024
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $1.51M. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Strome Mark ECIK 0000919484 | 10% Owner |
| Strome Investment Management LPCIK 0000936711 | 10% Owner |
| Strome Group, Inc.CIK 0001724136 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 26, 2024 | Common Stock | PPurchaseAcquired | +75,000 | $20.19 | +$1,514,250 | 398,683 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 26, 2024 | Common Stock | PPurchaseAcquired | +7,500 | $0.00 | $0 | 44,171 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.